cardiotomskСибирский журнал клинической и экспериментальной медициныSiberian Journal of Clinical and Experimental Medicine2713-29272713-265XTSU publishing10.29001/2073-8552-2025-2667cardiotomsk-2679Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESСовременные и будущие стратегии лечения эректильной дисфункции после нервосберегающей роботизированной радикальной простатэктомии (обзор литературы)Current and future strategies for managing erectile dysfunction following nerve-sparing robot-assisted radical prostatectomy (literature review)https://orcid.org/0000-0002-5160-925XГрицкевичА. А.GritskevichA. А.

Грицкевич Александр Анатольевич, д-р мед. наук, заведующий отделением онкоурологии и урологии, НМИЦ хирургии им. А.В. Вишневского Минздрава России; профессор кафедры урологии и оперативной нефрологии с курсом онкоурологии РУДН

117997, г. Москва, ул. Большая Серпуховская, 27;117198, г. Москва, ул. Миклухо-Маклая, 6

Alexander A. Gritskevich, Dr. Sci. (Med.), the Head of the Urology Department; professor of the Department of Urology and Operative Nephrology with course of Oncourology of the Medical Institute

27, Bolshaya Serpukhovskaya str., Moscow, 117997;6, Miklukho-Maklaya str., Moscow, 117198

grekaa@mail.ruhttps://orcid.org/0000-0002-3646-1664БайтманТ. П.BaitmanT. P.

Байтман Татьяна Павловна, канд. мед. наук, научный сотрудник отделения онкоурологии и урологии НМИЦ хирургии им. А.В. Вишневского Минздрава России; ассистент кафедры урологии и оперативной нефрологии с курсом онкоурологии РУДН

117997, г. Москва, ул. Большая Серпуховская, 27;117198, г. Москва, ул. Миклухо-Маклая, 6

Tatiana P. Baitman, Cand. Sci. (Med.), researcher of the Urology Department; assistant of the Department of Urology and Operative Nephrology with course of Oncourology of the Medical Institute

27, Bolshaya Serpukhovskaya str., Moscow, 117997;6, Miklukho-Maklaya str., Moscow, 117198

bit.t@mail.ruhttps://orcid.org/0009-0008-6626-761XБорукаевА. Ю.BorukaevA. U.

Борукаев Андемиркан Юриевич, аспирант 

117997, г. Москва, ул. Большая Серпуховская, 27

Andemirkan U. Borukaev, graduate student

27, Bolshaya Serpukhovskaya str., Moscow, 117997

antik.bor98@gmail.comhttps://orcid.org/0000-0002-0792-6012КостинА. А.КоstinA. А.

Костин Андрей Александрович, д-р мед. наук, чл.-корр. РАН, профессор РАН, первый проректор – проректор по научной работе РУДН, заведующий кафедрой урологии и оперативной нефрологии с курсом онкоурологии РУДН

117198, г. Москва, ул. Миклухо-Маклая, 6

Andrey A. Kostin, Dr. Sci. (Med.), Professor, Corresponding Member, Russian Academy of Sciences, First Vice-Rector for research, Head of Department of Urology and Operative Nephrology with course of Oncourology of the Medical Institute

6, Miklukho-Maklaya str., Moscow, 117198

https://orcid.org/0000-0002-7999-8955ИщенкоР. В.IshchenkoR. V.

Ищенко Роман Викторович, д-р мед. наук, директор ИНВХ им. В.К. Гусака Минздрава России

283045, Донецкая Народная Республика, г.о. Донецкий, Донецк, пр-кт Ленинский, 47

Roman V. Ishchenko, Dr. Sci. (Med.), the Director

47, Leninsky Ave., 283045, Donetsk urban district, Donetsk, Donetsk People's Republic

info@iursdn.ruhttps://orcid.org/0000-0002-4542-6860ФилимоновД. А.PhilimonovD. A.

Филимонов Дмитрий Алексеевич, д-р мед. наук, доцент, заместитель директора по научной работе 

283045, Донецкая Народная Республика, г.о. Донецкий, Донецк, пр-кт Ленинский, 47

Dmitry A. Philimonov, Dr. Sci. (Med.), associate professor, Deputy Director for Research

47, Leninsky Ave., 283045, Donetsk urban district, Donetsk, Donetsk People's Republic

info@iursdn.ruhttps://orcid.org/0000-0002-0174-5798ГолубицкийК. О.GolubitskiK. О.

Голубицкий Кирилл Олегович, канд. мед. наук, врач-хирург 

283045, Донецкая Народная Республика, г.о. Донецкий, Донецк, пр-кт Ленинский, 47

Kirill O. Golubitski, Cand. Sci. (Med.), surgeon

47, Leninsky Ave., 283045, Donetsk urban district, Donetsk, Donetsk People's Republic

info@iursdn.ruГлебоваА. Э.GlebovaA. E.

Глебова Альбина Эдуардовна, сотрудник отдела экспериментальной хирургии                        

283045, Донецкая Народная Республика, г.о. Донецкий, Донецк, пр-кт Ленинский, 47    

Albina E. Glebova, researcher of the Department of Experimental Surgery

47, Leninsky Ave., 283045, Donetsk urban district, Donetsk, Donetsk People's Republic

info@iursdn.ruНациональный медицинский исследовательский центр хирургии имени А.В. Вишневского Министерства здравоохранения Российской Федерации; Российский университет дружбы народов имени Патриса ЛумумбыРоссияA.V. Vishnevsky National Medical Research Center for Surgery; Peoples Friendship University of RussiaRussian FederationНациональный медицинский исследовательский центр хирургии имени А.В. Вишневского Министерства здравоохранения Российской Федерации; Российский университет дружбы народов имени Патриса ЛумумбыРоссияA.V. Vishnevsky National Medical Research Center for Surgery; Peoples Friendship University of RussiaRussian FederationНациональный медицинский исследовательский центр хирургии имени А.В. Вишневского Министерства здравоохранения Российской ФедерацииРоссияA.V. Vishnevsky National Medical Research Center for SurgeryRussian FederationРоссийский университет дружбы народов имени Патриса ЛумумбыРоссияPeoples Friendship University of RussiaRussian FederationИнститут неотложной и восстановительной хирургии имени В.К. Гусака Министерства здравоохранения Российской ФедерацииРоссияInstitute of Emergency and Reconstructive Surgery named after V.K. GusakRussian Federation2025130720254022131Copyright © Грицкевич А.А., Байтман Т.П., Борукаев А.Ю., Костин А.А., Ищенко Р.В., Филимонов Д.А., Голубицкий К.О., Глебова А.Э., 20252025Грицкевич А.А., Байтман Т.П., Борукаев А.Ю., Костин А.А., Ищенко Р.В., Филимонов Д.А., Голубицкий К.О., Глебова А.Э.Gritskevich A.А., Baitman T.P., Borukaev A.U., Коstin A.А., Ishchenko R.V., Philimonov D.A., Golubitski K.О., Glebova A.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.sibjcem.ru/jour/article/view/2679

Эректильная дисфункция (ЭД) является одним из наиболее часто развивающихся и значимо снижающих качество жизни осложнений радикальной простатэктомии (РПЭ). По данным ряда исследований, ЭД диагностируется у 60–75% пациентов после РПЭ. Применение нервосберегающей (НС) техники операции снизило частоту нарушений эрекции после РПЭ, однако полностью не решило данную проблему. Кроме того, сохранить сосудисто-нервные пучки не всегда представляется возможным по соображениям онкологической радикальности. Все вышеперечисленные факторы делают вопрос восстановления эректильной функции одним из приоритетных направлений медицинской реабилитации пациентов после радикального оперативного вмешательства по поводу рака предстательной железы (РПЖ). Разработка новых стратегий лечения ЭД после НС РПЭ, направленных на поддержание эндотелиальной функции в кавернозных артериях до завершения ремиелинизации и восстановления поврежденных кавернозных нервов, является актуальным и активно развивающимся направлением современной андрологии.

Erectile dysfunction (ED) is one of the most frequently developing and significantly reducing quality of life complications of radical prostatectomy (RPE). According to the number of studies, ED is diagnosed in 60-75% of patients after the RPE. The use of nerve-sparing surgical techniques has reduced the incidence of ED after RPE, but has not completely solved this problem. In addition, it is not always possible to preserve the vascular-nerve bundles for the reason of oncological radicalism. All of the above factors make the issue of restoring erectile function one of the priority areas of medical rehabilitation of patients after the radical surgery for prostate cancer (PC). The development of new strategies for the treatment of ED after NS RP, aimed at maintaining endothelial function in the cavernous arteries until the completion of remyelination and restoration of damaged cavernous nerves, is a relevant and actively developing area of modern andrology.

рак предстательной железыэректильная дисфункциянервосберегающая простатэктомияэндотелиальная дисфункцияprostate cancererectile dysfunctionnerve-sparing prostatectomysignaling pathwaysendothelial dysfunctionисследование выполнено за счет гранта Российского научного фонда № 24-75-00139, https://rscf.ru/project/24-75-00139/The study was supported by a grant from the Russian Science Foundation № 24-75-00139, https://rscf.ru/project/24-75-00139/ReferencesI. Bray F., Laversanne M., Sung H., Ferlay J., Siegel R.L., Soerjomataram et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2024;74(3):229–263. https://doi.org/10.3322/caac.21834I. Bray F., Laversanne M., Sung H., Ferlay J., Siegel R.L., Soerjomataram et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2024;74(3):229–263. https://doi.org/10.3322/caac.21834Montorsi F., Briganti A., Salonia A., Rigatti P., Burnett A.L. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur. Urol. 2004;45(2):123–33. https://doi.org/10.1016/j.eururo.2003.08.016Montorsi F., Briganti A., Salonia A., Rigatti P., Burnett A.L. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur. Urol. 2004;45(2):123–33. https://doi.org/10.1016/j.eururo.2003.08.016Носов Д.А., Волкова М.И., Гладков О.А., Карабина Е.В., Крылов В.В., Матвеев В.Б. и др. Рак предстательной железы. Практические рекомендации RUSSCO; часть 1.2. Злокачественные опухоли. 2024;14(3s2):242–269. https://doi.org/10.18027/2224-50572024-14-3s2-1.2-10Nosov D.A., Volkova M.I., Gladkov O.A. Karabina E.V., Krylov V.V., Matveev V.B. et al. Prostate cancer. RUSSCO practical recommendations, part 1.2. Malignant tumors. 2024;14(3s2):242–269. (In Russ.). https://doi.org/10.18027/2224-5057-2024-14-3s2-1.2-10Walsh P.C., Donker P.J. Impotence following radical prostatectomy: Insight into etiology and prevention. J. Urol. 2017;197(2S):S165–70. https://doi.org/10.1016/s0022-5347(17)53012-8Walsh P.C., Donker P.J. Impotence following radical prostatectomy: Insight into etiology and prevention. J. Urol. 2017;197(2S):S165–70. https://doi.org/10.1016/s0022-5347(17)53012-8Jiang N., Wu C., Zhou X., Zhai G., Wu J. Cavernous nerve injury resulted erectile dysfunction and regeneration. J. Immunol. Res. 2021;2021:5353785. https://doi.org/10.1155/2021/5353785Jiang N., Wu C., Zhou X., Zhai G., Wu J. Cavernous nerve injury resulted erectile dysfunction and regeneration. J. Immunol. Res. 2021;2021:5353785. https://doi.org/10.1155/2021/5353785Spirito L., Chessa F., Hagman A., Lantz A., Celentano G., Sanchez-Salas R. et al. Long-term oncological outcomes after nerve-sparing robot-assisted radical prostatectomy for high-risk localized prostate cancer: a single-center, two-arm prospective study. Diagnostics. 2024;14(8):803. https://doi.org/10.3390/diagnostics14080803Spirito L., Chessa F., Hagman A., Lantz A., Celentano G., Sanchez-Salas R. et al. Long-term oncological outcomes after nerve-sparing robot-assisted radical prostatectomy for high-risk localized prostate cancer: a single-center, two-arm prospective study. Diagnostics. 2024;14(8):803. https://doi.org/10.3390/diagnostics14080803Haga N., Miyazaki T., Tsubouchi K., Okabe Y., Shibayama K., Emoto D et al.Comprehensive approach for preserving cavernous nerves and erectile function after radical prostatectomy in the era of robotic surgery. Int. J. Urol. Off. J. JpnUrol. Assoc. 2021;28(4):360–368. https://doi.org/10.1111/iju.14491Haga N., Miyazaki T., Tsubouchi K., Okabe Y., Shibayama K., Emoto D et al.Comprehensive approach for preserving cavernous nerves and erectile function after radical prostatectomy in the era of robotic surgery. Int. J. Urol. Off. J. JpnUrol. Assoc. 2021;28(4):360–368. https://doi.org/10.1111/iju.14491Whalen M. Preventing erectile dysfunction after radical prostatectomy: nerve-sparing techniques, penile rehabilitation, and novel regenerative therapies. Open access peer-reviewed chapter. In: Genadiev T., ed. Prostatectomy [Internet]. IntechOpen; 2019. https://doi.org/10.5772/intechopen.79398Whalen M. Preventing erectile dysfunction after radical prostatectomy: nerve-sparing techniques, penile rehabilitation, and novel regenerative therapies. Open access peer-reviewed chapter. In: Genadiev T., ed. Prostatectomy [Internet]. IntechOpen; 2019. https://doi.org/10.5772/intechopen.79398Kyriazis I., Spinos T., Tsaturyan A., Kallidonis P., Stolzenburg J.U., Liatsikos E. Different Nerve-Sparing Techniques during Radical Prostatectomy and Their Impact on Functional Outcomes. Cancers. 2022;14(7):1601. https://doi.org/10.3390/cancers14071601Kyriazis I., Spinos T., Tsaturyan A., Kallidonis P., Stolzenburg J.U., Liatsikos E. Different Nerve-Sparing Techniques during Radical Prostatectomy and Their Impact on Functional Outcomes. Cancers. 2022;14(7):1601. https://doi.org/10.3390/cancers14071601Mandel P., Preisser F., Graefen M., Steuber T., Salomon G., Haese A. et al. High chance of late recovery of urinary and erectile function beyond 12 months after radical prostatectomy. Eur. Urol. 2017;71:848–850. https://doi.org/10.1016/j.eururo.2016.09.030Mandel P., Preisser F., Graefen M., Steuber T., Salomon G., Haese A. et al. High chance of late recovery of urinary and erectile function beyond 12 months after radical prostatectomy. Eur. Urol. 2017;71:848–850. https://doi.org/10.1016/j.eururo.2016.09.030Noldus J., Michl U., Graefen M., Haese A., Hammerer P., Huland H. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur. Urol. 2002;42(2):118–124. https://doi.org/10.1016/s0302-2838(02)00219-1Noldus J., Michl U., Graefen M., Haese A., Hammerer P., Huland H. Patient-reported sexual function after nerve-sparing radical retropubic prostatectomy. Eur. Urol. 2002;42(2):118–124. https://doi.org/10.1016/s0302-2838(02)00219-1de Carvalho P.A., Barbosa J.A.B.A., Guglielmetti G.B., Cordeiro M.D., Rocco B., Nahas W.C. et al. Retrograde release of the neurovascular bundle with preservation of dorsal venous complex during robot-assisted radical prostatectomy: Optimizing functional outcomes. Eur. Urol. 2020;77(5):628–635. https://doi.org/10.1016/j.eururo.2018.07.003de Carvalho P.A., Barbosa J.A.B.A., Guglielmetti G.B., Cordeiro M.D., Rocco B., Nahas W.C. et al. Retrograde release of the neurovascular bundle with preservation of dorsal venous complex during robot-assisted radical prostatectomy: Optimizing functional outcomes. Eur. Urol. 2020;77(5):628–635. https://doi.org/10.1016/j.eururo.2018.07.003Haese A., Knipper S., Isbarn H., Heinzer H., Tilki D., Salomon G. et al. A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures. BJU Int. 2019;123(6):1031–1040. https://doi.org/10.1111/bju.14760Haese A., Knipper S., Isbarn H., Heinzer H., Tilki D., Salomon G. et al. A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both procedures. BJU Int. 2019;123(6):1031–1040. https://doi.org/10.1111/bju.14760Maruo M., Goto Y., Miyazaki K., Inoue A., Kurokawa K., Enomoto A. et al. Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon. Sci. Rep. 2024;14(1):926. https://doi.org/10.1038/s41598-024-51598-3Maruo M., Goto Y., Miyazaki K., Inoue A., Kurokawa K., Enomoto A. et al. Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon. Sci. Rep. 2024;14(1):926. https://doi.org/10.1038/s41598-024-51598-3Egan J., Marhamati S., Carvalho F.L.F., Davis M., O’Neill J., Lee H. et al. Retzius-sparing Robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise on oncologic efficacy: Single-surgeon series and step-by-step guide. Eur. Urol. 2021;79(6):839–857. https://doi.org/10.1016/j.eururo.2020.05.010Egan J., Marhamati S., Carvalho F.L.F., Davis M., O’Neill J., Lee H. et al. Retzius-sparing Robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical prostatectomy without compromise on oncologic efficacy: Single-surgeon series and step-by-step guide. Eur. Urol. 2021;79(6):839–857. https://doi.org/10.1016/j.eururo.2020.05.010MacDonald S.M., Burnett A.L. Physiology of Erection and Pathophysiology of Erectile Dysfunction. Urol Clin. North Am. 2021;48(4):513–525. https://doi.org/10.1016/j.ucl.2021.06.009MacDonald S.M., Burnett A.L. Physiology of Erection and Pathophysiology of Erectile Dysfunction. Urol Clin. North Am. 2021;48(4):513–525. https://doi.org/10.1016/j.ucl.2021.06.009Argiolas A., Argiolas F.M., Argiolas G., Melis M.R. Erectile dysfunction: treatments, advances and new therapeutic strategies. Brain Sci. 2023;13(5):802. https://doi.org/10.3390/brainsci13050802Argiolas A., Argiolas F.M., Argiolas G., Melis M.R. Erectile dysfunction: treatments, advances and new therapeutic strategies. Brain Sci. 2023;13(5):802. https://doi.org/10.3390/brainsci13050802Lukovic E., Emala C. Diacylglycerol kinase puts the brakes on airway smooth muscle contraction. Am. J. Respir. Cell. Mol. Biol. 2021;65(6):578–580. https://doi.org/10.1165/rcmb.2021-0325EDLukovic E., Emala C. Diacylglycerol kinase puts the brakes on airway smooth muscle contraction. Am. J. Respir. Cell. Mol. Biol. 2021;65(6):578–580. https://doi.org/10.1165/rcmb.2021-0325EDOmirinde J.O., Azeez I.A. Neuropeptide profiles of mammalian male genital tract: distribution and functional relevance in reproduction. Front. Vet. Sci. 2022;9:842515. https://doi.org/10.3389/fvets.2022.842515Omirinde J.O., Azeez I.A. Neuropeptide profiles of mammalian male genital tract: distribution and functional relevance in reproduction. Front. Vet. Sci. 2022;9:842515. https://doi.org/10.3389/fvets.2022.842515Kong L., Gao X., Qian Y., Sun W., You Z., Fan C. Biomechanical microenvironment in peripheral nerve regeneration: from pathophysiological understanding to tissue engineering development. Theranostics. 2022;12(11):4993–5014. https://doi.org/10.7150/thno.74571Kong L., Gao X., Qian Y., Sun W., You Z., Fan C. Biomechanical microenvironment in peripheral nerve regeneration: from pathophysiological understanding to tissue engineering development. Theranostics. 2022;12(11):4993–5014. https://doi.org/10.7150/thno.74571De Leonardis F., Colalillo G., FinazziAgrò E., Miano R., Fuschi A., Asimakopoulos A.D. Endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines. 2022;10(8):1848. https://doi.org/10.3390/biomedicines10081848De Leonardis F., Colalillo G., FinazziAgrò E., Miano R., Fuschi A., Asimakopoulos A.D. Endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines. 2022;10(8):1848. https://doi.org/10.3390/biomedicines10081848Belenichev I., Popazova O., Bukhtiyarova N., Savchenko D., Oksenych V., Kamyshnyi O. Modulating nitric oxide: implications for cytotoxicity and cytoprotection. Antioxid. Basel Switz. 2024;13(5):504. https://doi.org/10.3390/antiox13050504Belenichev I., Popazova O., Bukhtiyarova N., Savchenko D., Oksenych V., Kamyshnyi O. Modulating nitric oxide: implications for cytotoxicity and cytoprotection. Antioxid. Basel Switz. 2024;13(5):504. https://doi.org/10.3390/antiox13050504Musicki B., Bhunia A.K., Karakus S., Burnett A.L. S-nitrosylation of NOS pathway mediators in the penis contributes to cavernous nerve injury-induced erectile dysfunction. Int. J. Impot. Res. 2018;30(3):108–116. https://doi.org/10.1038/s41443-018-0021-yMusicki B., Bhunia A.K., Karakus S., Burnett A.L. S-nitrosylation of NOS pathway mediators in the penis contributes to cavernous nerve injury-induced erectile dysfunction. Int. J. Impot. Res. 2018;30(3):108–116. https://doi.org/10.1038/s41443-018-0021-yNoh T.I., Shim J.S., Kang S.G., Cheon J., Lee J.G., Kang S.H. Efficacy of tadalafil in penile rehabilitation started before nerve-sparing robot-assisted radical prostatectomy: a double-blind pilot study. Sex Med. 2022;10(3):100508. https://doi.org/10.1016/j.esxm.2022.100508Noh T.I., Shim J.S., Kang S.G., Cheon J., Lee J.G., Kang S.H. Efficacy of tadalafil in penile rehabilitation started before nerve-sparing robot-assisted radical prostatectomy: a double-blind pilot study. Sex Med. 2022;10(3):100508. https://doi.org/10.1016/j.esxm.2022.100508Sari Motlagh R., Abufaraj M., Yang L., Mori K., Pradere B., Laukhtina E. et al. Penile rehabilitation strategy after nerve sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials. J. Urol. 2021;205(4):1018–1030. https://doi.org/10.1097/JU.0000000000001584Sari Motlagh R., Abufaraj M., Yang L., Mori K., Pradere B., Laukhtina E. et al. Penile rehabilitation strategy after nerve sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials. J. Urol. 2021;205(4):1018–1030. https://doi.org/10.1097/JU.0000000000001584Goh H.J., Sung J.M., Lee K.H., Jo J.K., Kim K.N. Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis. Transl. Androl. Urol. 2022;11(2):124–138. https://doi.org/10.21037/tau-21-881Goh H.J., Sung J.M., Lee K.H., Jo J.K., Kim K.N. Efficacy of phosphodiesterase type 5 inhibitors in patients with erectile dysfunction after nerve-sparing radical prostatectomy: a systematic review and meta-analysis. Transl. Androl. Urol. 2022;11(2):124–138. https://doi.org/10.21037/tau-21-881Cecerska-Heryć E., Heryć R., Wiśniewska M., Michalczyk A., Dołęgowska B. Regenerative potential of platelets in patients with chronic kidney disease. Int. Urol. Nephrol. 2019;51(10):1831–1840. https://doi.org/10.1007/s11255-019-02190-6Cecerska-Heryć E., Heryć R., Wiśniewska M., Michalczyk A., Dołęgowska B. Regenerative potential of platelets in patients with chronic kidney disease. Int. Urol. Nephrol. 2019;51(10):1831–1840. https://doi.org/10.1007/s11255-019-02190-6Wu C.C., Wu Y.N., Ho H.O., Chen K.C., Sheu M.T., Chiang H.S. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J. Sex Med. 2012;9(11):2838– 2848. https://doi.org/10.1111/j.1743-6109.2012.02881.xWu C.C., Wu Y.N., Ho H.O., Chen K.C., Sheu M.T., Chiang H.S. The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J. Sex Med. 2012;9(11):2838– 2848. https://doi.org/10.1111/j.1743-6109.2012.02881.xPoulios E., Mykoniatis I., Pyrgidis N., Zilotis F., Kapoteli P., Kotsiris D. et al. Platelet-Rich Plasma (PRP) Improves erectile function: a double-blind, randomized, placebo-controlled clinical trial. J. Sex Med. 2021;18(5):926–935. https://doi.org/10.1016/j.jsxm.2021.03.008Poulios E., Mykoniatis I., Pyrgidis N., Zilotis F., Kapoteli P., Kotsiris D. et al. Platelet-Rich Plasma (PRP) Improves erectile function: a double-blind, randomized, placebo-controlled clinical trial. J. Sex Med. 2021;18(5):926–935. https://doi.org/10.1016/j.jsxm.2021.03.008Inoue S., Hayashi T., Teishima J., Matsubara A. Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy. Transl. Androl. Urol. 2020;9(4):1559–1565. https://doi.org/0.21037/tau19-888Inoue S., Hayashi T., Teishima J., Matsubara A. Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy. Transl. Androl. Urol. 2020;9(4):1559–1565. https://doi.org/0.21037/tau19-888Kohada Y., Babasaki T., Goto K., Inoue S., Kurimura Y., Tasaka R. et al. Long-term efficacy of penile rehabilitation with low-intensity extracorporeal shock wave therapy for sexual and erectile function recovery following robotic-assisted radical prostatectomy: a single-cohort pilot study. Sex Med. 2023;11(2):qfad023. https://doi.org/10.1093/sexmed/qfad023Kohada Y., Babasaki T., Goto K., Inoue S., Kurimura Y., TasakaR. et al. Long-term efficacy of penile rehabilitation with low-intensity extracorporeal shock wave therapy for sexual and erectile function recovery following robotic-assisted radical prostatectomy: a single-cohort pilot study. Sex Med. 2023;11(2):qfad023. https://doi.org/10.1093/sexmed/qfad023Matthew A.N., Rogers D.E., Grob G., Blottner M., Kodama S., Krzastek S.C. The use of low-intensity extracorporeal shockwave therapy in management of erectile dysfunction following prostate cancer treatment: a review of the current literature. Transl. Androl. Urol. 2023;12(6):1023–1032. https://doi.org/10.21037/tau-22-791Matthew A.N., Rogers D.E., Grob G., Blottner M., Kodama S., Krzastek S.C. The use of low-intensity extracorporeal shockwave therapy in management of erectile dysfunction following prostate cancer treatment: a review of the current literature. Transl. Androl. Urol. 2023;12(6):1023–1032. https://doi.org/10.21037/tau-22-791Епифанова М.В. Применение технологий регенеративной медицины при сексуальной дисфункции и нарушении фертильности у мужчин: дис. … д-ра мед. наук. М.,2022:400. Режим доступа: https://dissovet.rostgmu.ru (13.05.2025).Epifanova M.V. Application of regenerative medicine technologies in sexual functions and infertility disorders in men: diss. … doctor of medical sciences. Moscow, 2022:400. (In Russ.). URL: https://dissovet.rostgmu.ru (13.05.2025).Кузник Б.И., Рыжак Г.А., Хавинсон В.Х. Полипептидный комплекс сосудов и его роль в регуляции физиологических функций при возрастной патологии. Успехи геронтологии. 2019;32(1–2):174–179. URL: https://khavinson.info/assets/files/russ/2019-kuznik_ryzhak.pdf (13.05.2025).Kuznik B.I., Ryzhak G.A., KhavinsonV.Kh. Polypeptide vessel complex and its role in physiology function regulation in aging pathology. Advances in Gerontology. 2019;32(1–2):174–179. (In Russ). URL: https:// khavinson.info/assets/files/russ/2019-kuznik_ryzhak.pdf (13.05.2025).Хоченкова Ю.А., Хоченков Д.А., Коржова К.В., Кажарская Е.Ю., Мачкова Ю.С., Сидорова Т.А. Ангиопротекторный и регенеративный потенциал полипептидного препарата Славинорм при эндотелиальной дисфункции и атеросклеротическом поражении сосудов. Эффективная фармакотерапия. 2023;19(5):24–31. https://doi.org/10.33978/2307-3586-2023-19-5-24-31Khochenkova Yu.A., Khochenkov D.A., KorzhovaK.V., Kazharskaya Ye.Yu., Machkova Yu.S., Sidorova T.A. Angioprotective and regenerative potential of the polypeptide drug slavinorm in endothelial dysfunction and atherosclerotic vascular lesions. Effective pharmacotherapy. 2023;19(5):24–31. (In Russ.). https://doi.org/10.33978/2307-3586-2023-19-5-24-31Сучков И.А., Калинин Р.Е., Мжаванадзе Н.Д., Камаев А.А., Буренин А.Г., Ларьков Р.Н. Эффективность и безопасность применения препарата на основе регуляторных полипептидов сосудов для лечения перемежающейся хромоты (результаты многоцентрового двойного слепого плацебо-контролируемого рандомизированного исследования). Ангиология и сосудистая хирургия. 2023;29(1):23–33. https://doi.org/10.33029/1027-6661-202329-1-23-33Suchkov I.A., Kalinin R.E., Mzhavanadze N.D., Kamaev A.A., Burenin A.G., Larkov R.N. Efficacy and safety of a drug based on vascular regulatory polypeptides for the treatment of intermittent claudication (results of a multicenter, double-blind, placebo-controlled randomized trial). Angiology and Vascular Surgery. 2023;29(1):3–33. (In Russ.). https://doi.org/10.33029/1027-6661-2023-29-1-23-33Jabir N.R., Firoz C.K., Zughaibi T.A., Alsaadi M.A., Abuzenadah A.M., Al-Asmari A.I. et al. A literature perspective on the pharmacological applications of yohimbine. Ann. Med. 2022;54(1):2861–2875. https://doi.org/10.1080/07853890.2022.2131330Jabir N.R., Firoz C.K., Zughaibi T.A., Alsaadi M.A., Abuzenadah A.M., Al-Asmari A.I. et al. A literature perspective on the pharmacological applications of yohimbine. Ann. Med. 2022;54(1):2861–2875. https://doi.org/10.1080/07853890.2022.2131330Pyke R.E. Trazodone in sexual medicine: underused and overdosed? Sex Med. Rev. 2020;8(2):206–216. https://doi.org/10.1016/j.sxmr.2018.08.003Pyke R.E. Trazodone in sexual medicine: underused and overdosed? Sex Med. Rev. 2020;8(2):206–216. https://doi.org/10.1016/j.sxmr.2018.08.003Melis M.R., Sanna F., Argiolas A. Dopamine, erectile function and male sexual behavior from the past to the present: a review. Brain Sci. 2022;12(7):826. https://doi.org/10.3390/brainsci12070826Melis M.R., Sanna F., Argiolas A. Dopamine, erectile function and male sexual behavior from the past to the present: a review. Brain Sci. 2022;12(7):826. https://doi.org/10.3390/brainsci12070826Dorr R.T., Lines R., Levine N., Brooks C., Xiang L., Hruby V.J. et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777–1784. https://doi.org/10.1016/0024-3205(96)00160-9Dorr R.T., Lines R., Levine N., Brooks C., Xiang L., Hruby V.J. et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777–1784. https://doi.org/10.1016/0024-3205(96)00160-9Wessells H., Fuciarelli K., Hansen J., Hadley M.E., Hruby V.J., Dorr R. et al. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J. Urol. 1998;160(2):389–393. https://doi.org/10.1016/S00225347(01)62903-3Wessells H., Fuciarelli K., Hansen J., Hadley M.E., Hruby V.J., Dorr R. et al. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J. Urol. 1998;160(2):389–393. https://doi.org/10.1016/S00225347(01)62903-3Kim S., Cho M.C., Cho S.Y., Chung H., Rajasekaran M.R. Novel emerging therapies for erectile dysfunction. World J. Men's Health. 2021;39(1):48–64. https://doi.org/10.5534/wjmh.200007Kim S., Cho M.C., Cho S.Y., Chung H., Rajasekaran M.R. Novel emerging therapies for erectile dysfunction. World J. Men's Health. 2021;39(1):48–64. https://doi.org/10.5534/wjmh.200007Diamond L.E., Earle D.C., Rosen R.C., Willett M.S., Molinoff P.B. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int. J. Impot. Res. 2004;16(1):51–59. https://doi.org/10.1038/sj.ijir.3901139Diamond L.E., Earle D.C., Rosen R.C., Willett M.S., Molinoff P.B. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int. J. Impot. Res. 2004;16(1):51–59. https://doi.org/10.1038/sj.ijir.3901139Safarinejad M.R., Hosseini S.Y. Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. J. Urol. 2008;179(3):1066–1071. https://doi.org/10.1016/j.juro.2007.10.063Safarinejad M.R., Hosseini S.Y. Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. J. Urol. 2008;179(3):1066–1071. https://doi.org/10.1016/j.juro.2007.10.063Diamond L.E., Earle D.C., Garcia W.D., Spana C. Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology. 2005;65(4):755–759. https://doi.org/10.1016/j.urology.2004.10.060Diamond L.E., Earle D.C., Garcia W.D., Spana C. Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology. 2005;65(4):755–759. https://doi.org/10.1016/j.urology.2004.10.060Ren Y., Yuan J., Xue Y.,Zhang Y., Li S., Liu C.et al. Advanced hydrogels: New expectation for the repair of organic erectile dysfunction. Mater. Today Bio. 2023;19:100588. https://doi.org/10.1016/j.mtbio.2023.100588Ren Y., Yuan J., Xue Y.,Zhang Y., Li S., Liu C.et al. Advanced hydrogels: New expectation for the repair of organic erectile dysfunction. Mater. Today Bio. 2023;19:100588. https://doi.org/10.1016/j.mtbio.2023.100588Choe S., Kalmanek E., Bond C., Harrington D.A., Stupp S.I., McVary K.T. et al. Optimization of sonic hedgehog delivery to the penis from self-assembling nanofiber hydrogels to preserve penile morphology after cavernous nerve injury. Nanomedicine Nanotechnol. Biol. Med. 2019;20:102033. https://doi.org/10.1016/j.nano.2019.102033Choe S., Kalmanek E., Bond C., Harrington D.A., Stupp S.I., McVary K.T. et al. Optimization of sonic hedgehog delivery to the penis from self-assembling nanofiber hydrogels to preserve penile morphology after cavernous nerve injury. Nanomedicine Nanotechnol. Biol. Med. 2019;20:102033. https://doi.org/10.1016/j.nano.2019.102033Martin S., Harrington D.A., Ohlander S., Stupp S.I., McVary K.T., Podlasek C.A. Peptide amphiphile nanofiber hydrogel delivery of Sonic hedgehog protein to the penis and cavernous nerve suppresses intrinsic and extrinsic apoptotic signaling mechanisms, which are an underlying cause of erectile dysfunction. Nanomedicine Nanotechnol. Biol Med. 2021;37:102444. https://doi.org/10.1016/j.nano.2021.102444Martin S., Harrington D.A., Ohlander S., Stupp S.I., McVary K.T., Podlasek C.A. Peptide amphiphile nanofiber hydrogel delivery of Sonic hedgehog protein to the penis and cavernous nerve suppresses intrinsic and extrinsic apoptotic signaling mechanisms, which are an underlying cause of erectile dysfunction. Nanomedicine Nanotechnol. Biol Med. 2021;37:102444. https://doi.org/10.1016/j.nano.2021.102444Wang C.M., Wu B.R., Xiang P., Xiao J., Hu X.C. Management of male erectile dysfunction: From the past to the future. Front. Endocrinol. 2023;14:1148834. https://doi.org/10.3389/fendo.2023.1148834Wang C.M., Wu B.R., Xiang P., Xiao J., Hu X.C. Management of male erectile dysfunction: From the past to the future. Front. Endocrinol. 2023;14:1148834. https://doi.org/10.3389/fendo.2023.1148834Zhao W., Sun J., Yao L.Y., Hang D., Li Y.Q., Chen C.P. et al. MYPT1 reduction is a pathogenic factor of erectile dysfunction. Commun. Biol. 2022;5(1):744. https://doi.org/10.1038/s42003-022-03716-yZhao W., Sun J., Yao L.Y., Hang D., Li Y.Q., Chen C.P. et al. MYPT1 reduction is a pathogenic factor of erectile dysfunction. Commun. Biol. 2022;5(1):744. https://doi.org/10.1038/s42003-022-03716-y

The authors declare that there are no conflicts of interest present.